Fièvre et syndrome inflammatoire inexpliqué chez le sujet âgé, impact thérapeutique de la TEP-TDM au 18F-FDG
Carole Greuez(Université de Strasbourg), Emmanuel Andrès(Université de Strasbourg), Alessio Impériale(Institut de Cancérologie Strasbourg), Stéphane Giorgiutti(Inserm), Bernard Goichot(Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine), M. Rondeau-Lutz(Hôpitaux Universitaires de Strasbourg), C. Lenormand(Hôpitaux Universitaires de Strasbourg), Georges Kaltenbach(Hôpitaux Universitaires de Strasbourg), E. Schmitt(Universidade Estadual do Oeste do Paraná), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Xavier Argemi(AlmavivA (Italy)), Nicolas Lefèbvre(Université de Strasbourg), Bruno Moulin(Université de Strasbourg), S. Lescuyer(Hôpitaux Universitaires de Strasbourg), Thierry Hannedouche
Cited by 0
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing
|Clinical Pharmacology & Therapeutics|2010|363
The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study
|Clinical Journal of the American Society of Nephrology|2016|192